DCH Auriga selected as the logistics partner to distribute the Fosun Pharma-BioNTech COVID-19 vaccine in Hong Kong

DCH Auriga, the PHCbi’s official distributors in Hong Kong with decades of experience managing sophisticated pharmaceutical supply chains, is pleased to announced it had been selected to manage the storage and delivery of the Fosun Pharma-BioNTech BNT162b2 vaccine in Hong Kong as the exclusive logistics partner of Shanghai Fosun Pharmaceutical (Group) Co., Limited (Stock Code: 600196.SH, 02196.HK) and Jacobson Pharma Corporation Limited (Stock Code: 2633).

Under the agreement, DCH Auriga Hong Kong Ltd. will leverage its specialty cold chain expertise and unique healthcare-dedicated infrastructure to provide Ultra Low Temperature storage and distribution for the safe and timely supply of the COVID-19 vaccine.

Tim Collins, the CEO of DCH Auriga said, “We are honoured to support this vital vaccination program and play a part in protecting the health and well-being of our communities. As long-time partners of the public health system and specialists in cold chain distribution for the healthcare industry, we are well experienced in handling Ultra Low temperature requirements with highly trained staff and robust quality assurance protocols. We are confident in our ability to deliver this vaccine safely and securely, in full accordance with the directives of the Government and Department of Health.”

Original source (Corporate web site of DCH Auriga)
DCH Auriga (Hong Kong) Ltd – Headquarter
11/F Wyler Centre I, 202-210 Tai Lin Pai Road, Kwai Chung, Hong Kong SAR

PHCbi TwinGuard Ultra-low Temperature Freezers